Reflecting on last year's achievements and challenges in public health, ensuring a healthier world through universal coverage remains the overarching goal for 2026.

Explore the most influential drug approvals of 2025, highlighting FDA-cleared therapies that impact public health and clinical care.

The World Health Organisation (WHO) has described 2025 as a challenging year, marked by unprecedented disruption following ...

Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...

In 2026, AI will continue threading itself into behavioral health, and the bar will rise sharply for what counts as ...

Lenacapavir, a long-acting injectable PrEP, requires two injections annually, marking a significant advancement in HIV ...

Dr Robert Mutumba, the head of the Aids Control Programme at the Ministry of Health, told Daily Monitor that Ugandans are ...

Dear friends, colleagues and partners,As this year comes to a close, we stand at a defining crossroads in the global effort to end HIV, tuberculosis (TB), viral hepatitis, and sexually transmitted ...

Lenacapavir demonstrated high effectiveness as pre-exposure prophylaxis (PrEP) in clinical trials conducted among adolescent girls and young women in Uganda and South Africa. Following these results, ...

Time magazine has named Czech virologist Tomáš Cihlář among its 100 Most Influential People of 2025, recognising his work on ...

Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...

The Trump administration’s new global HIV prevention strategy prioritizes preventing mother-to-child HIV transmission. About 120,000 children under the age of 5 were newly infected with HIV in 2024, ...